Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates.
The Danish weight-loss drug maker is looking to regain momentum following a tumultuous year in which it fell behind rival Eli Lilly.
This is a breaking news story. Please refresh for updates.
Source: CNBC · Elsa Ohlen
At a glance
- Topic
- Business
- Country
- 🇺🇸 US
- Publisher language
- EN
- Added to Allnira